Dabigatran versus warfarin for venous thromboembolism.
Teachey
David T
DT
D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000191:economics* / Q000627:therapeutic use; D000069604:Dabigatran; D016527:Drug Costs; D006801:Humans; D019934:International Normalized Ratio; D011725:Pyridines / Q000191:economics* / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000191:economics* / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran